Stay updated on Pembrolizumab for Desmoplastic Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe page revision tag changed from v3.6.3 to v3.6.4, indicating an updated version of the page. This update appears to be a backend/content-management change with no substantive modification to the trial details.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedNew update timestamps were added and older ones removed, reflecting the latest revision history of the study record.SummaryDifference0.1%

- Check33 days agoChange DetectedThree new study sites were added (CommonSpirit Saint Joseph Hospital Bardstown; CommonSpirit Saint Joseph Medical Center East Lexington; CommonSpirit Saint Joseph Hospital London), and three existing sites were removed (Flaget Memorial Hospital; Saint Joseph Hospital East; Saint Joseph London). The page includes a new revision tag (v3.6.3).SummaryDifference0.1%

- Check40 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2 on the page, reflecting a software/layout update. This change does not modify the study content or the information presented about the trial.SummaryDifference0.0%

- Check47 days agoChange DetectedCreighton University Medical Center in Omaha was removed from the study site list and the total number of locations decreased from 281 to 280. This change reflects updated site availability for the trial.SummaryDifference0.1%

- Check55 days agoChange DetectedRecruitment status updated to 'No longer looking for participants'. The page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment label, while removing the older 'Intervention / Treatment' label and the previous revision note 'Revision: v3.5.5' and adding 'Revision: v3.6.0'.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Desmoplastic Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page.